NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
Back to search
Official data from USPTO
LYELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
10/22/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
05/04/2021
Registration date
10/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/05/2023
First use in commerce
01/05/2023
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA
Examiner
BRECKENFELD,WILLIAM G
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Lyell" surrounded by three incomplete circles each of which has an opening at the right.
Holders and representatives
Holders
Lyell Immunopharma, Inc.
Representatives
Christina L. Martini MCDERMOTT WILL & EMERY LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
Class 42
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific research; biological research and developmentresearch and development utilizing integrated technology platforms combining chemicalmoleculargeneticprotein and cell systems engineering technologies for therapeutic regulation of cells and cell systemstherapeutic regulation of immune cells; biological research and developmentresearch and development related to treatment of cancer
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/01/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/19/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/18/2025
IUAF
USE AMENDMENT FILED
04/25/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/25/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/29/2024
EX5G
SOU EXTENSION 5 GRANTED
10/29/2024
EXT5
SOU EXTENSION 5 FILED
10/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2024
EX4G
SOU EXTENSION 4 GRANTED
04/29/2024
EXT4
SOU EXTENSION 4 FILED
04/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2023
EX3G
SOU EXTENSION 3 GRANTED
10/30/2023
EXT3
SOU EXTENSION 3 FILED
10/30/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/30/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/18/2023
EX2G
SOU EXTENSION 2 GRANTED
04/14/2023
EXT2
SOU EXTENSION 2 FILED
04/14/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/14/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/18/2022
EX1G
SOU EXTENSION 1 GRANTED
10/14/2022
EXT1
SOU EXTENSION 1 FILED
10/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2022
PUBO
PUBLISHED FOR OPPOSITION
03/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/14/2021
GNRT
NON-FINAL ACTION E-MAILED
10/14/2021
CNRT
NON-FINAL ACTION WRITTEN
10/14/2021
DOCK
ASSIGNED TO EXAMINER
10/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/01/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/01/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2021
NWAP
NEW APPLICATION ENTERED
05/07/2021
Continuous trademark protection
Get notified about every new filing that threatens LYELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.